Хірургічне втручання у пацієнтів, які проходять антитромбоцитарну терапію 9 страница

687. Haude M, Erbel R, Erne P, Verheye S, Degen H, Bose D, Vermeersch P,­Wijnbergen I,Weissman N, Prati F,Waksman R, Koolen J. Safety and performance­of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo­coronary lesions: 12 month results of the prospective, multicentre, first-in-man­BIOSOLVE-I trial. Lancet 2013;381(9869):836–844

688. Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, Costa JR Jr.,­Chamie D, Abizaid AS, Pinto I, Morrison L, Toyloy S, Bhat V, Yan J, Abizaid A. A­Next-Generation Bioresorbable Coronary Scaffold System-From Bench to First­Clinical Evaluation: Six- and 12-Month Clinical and Multimodality Imaging­Results. JACC Cardiovasc Interv 2013;7(1):89–99

689. Maier LS, Maack C, Ritter O, Bohm M. Hotline update of clinical trials and registries­presented at theGerman Cardiac Society meeting 2008. (PEPCAD,LokalTax, INH,­German ablation registry, German device registry, DES.DE registry, DHR, Reality,­SWEETHEART registry, ADMA, GERSHWIN). Clin Res Cardiol 2008;97(6):­356–363

690. Fischer D, Scheller B, Schafer A, Klein G,Bohm M, CleverY, Cremers B. Paclitaxcelcoated­balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions:­an IVUS study. EuroIntervention 2012;8(4):450–455

691. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T,­Politi L, Doevendans PA, SangiorgiGM, Stella PR. First results of the DEB-AMI (drug­eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter­randomized comparison of drug-eluting balloon plus bare-metal stent vs bare-metal stent vs. drug-eluting stent in primary percutaneous coronary intervention­with 6-month angiographic, intravascular, functional, and clinical outcomes. J­Am Coll Cardiol 2012;59(25):2327–2337

692. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A,­Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A Arandomized multicenter study comparing a paclitaxel drug-eluting balloon with a­paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and­Late Loss Optimization) study. J Am Coll Cardiol 2012;60(24):2473–2480

693. Bondesson P, Lagerqvist B, James SK, Olivecrona GK, Venetsanos D, Harnek J Comparison of two drug-eluting balloons: a report from the SCAAR registry. Euro-­Intervention 2012;8(4):444–449

694. Stella PR, Belkacemi A,Waksman R, Stahnke S, Torguson R, von Strandmann RP,­Agostoni P, Sangiorgi G, Silber S. The Valentines Trial: results of the first one­week worldwide multicentre enrolment trial, evaluating the real world usage of­the second generation DIORpaclitaxel drug-eluting balloon for in-stent restenosis­treatment. EuroIntervention 2011;7(6):705–710

695. Waksman R, Serra A, Loh JP, Malik FT, Torguson R, Stahnke S, von Strandmann RP,­Rodriguez AE. Drug-coated balloons for de novo coronary lesions: results from the­Valentines II trial. EuroIntervention 2013;9(5):613–619

696. Gutierrez-Chico JL, van Geuns RJ, Koch KT, Koolen JJ, Duckers H, Regar E,­Serruys PW. Paclitaxel-coated balloon in combination with bare metal stent for­treatment of de novo coronary lesions: an optical coherence tomography­first-in-human randomised trial, balloon first vs. stent first. EuroIntervention 2011;­7(6):711–722

697. Hehrlein C, Dietz U, Kubica J, Jorgensen E, Hoffmann E, Naber C, Lesiak M,­Schneider H, Wiemer M, Tolg R, Richardt G. Twelve-month results of a paclitaxel­releasing balloon in patients presenting with in-stent restenosis First-in-Man­(PEPPER) trial. Cardiovasc Revasc Med 2012;13(5):260–264

698. Abdel-Wahab M, Richardt G, Joachim Buttner H, Toelg R, Geist V, Meinertz T,­Schofer J, King L, Neumann FJ, Khattab AA. High-speed rotational atherectomy­before paclitaxel-eluting stent implantation in complex calcified coronary­lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus­Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc­Interv 2013;6(1):10–19

699. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ,­Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology Clinical­Expert Consensus Document on Standards for Acquisition, Measurement,­Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American­College of Cardiology Task Force on Clinical Expert Consensus Documents. J­Am Coll Cardiol 2001;37(5):1478–1492

700. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J,­Magorien RD, O’Shaughnessy C, Ganz P, Reversal of Atherosclerosis with Aggressive­Lipid Lowering I. Statin therapy, LDL cholesterol, C-reactive protein, and coronary­artery disease. N Engl J Med 2005;352(1):29–38

701. Mintz GS, Garcia-Garcia HM, Nicholls SJ, Weissman NJ, Bruining N, Crowe T,­Tardif JC, SerruysPW. Clinical expert consensus document on standards for acquisition,­measurement and reporting of intravascular ultrasound regression/progression­studies. EuroIntervention 2011;6(9):1123–1130, 9

702. Casella G, Klauss V, Ottani F, Siebert U, Sangiorgio P, Bracchetti D. Impact of intravascular­ultrasound-guided stenting on long-term clinical outcome: a meta-analysis­of available studies comparing intravascular ultrasound-guided and angiographically­guided stenting. Catheter Cardiovasc Interv 2003;59(3):314–321

703. Parise H, Maehara A, StoneGW, Leon MB, Mintz GS. Meta-analysis of randomized­studies comparing intravascular ultrasound vs. angiographic guidance of percutaneous­coronary intervention in pre-drug-eluting stent era. Am J Cardiol 2011;107(3):­374–382

704. Zhang Y, Farooq V, Garcia-Garcia HM, Bourantas CV, Tian N, Dong S, Li M, Yang S,­Serruys PW, Chen SL. Comparison of intravascular ultrasound vs. angiographyguided­drug-eluting stent implantation: a meta-analysis of one randomised trial­and ten observational studies involving 19,619 patients. EuroIntervention 2012;­8(7):855–865

705. Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, Suh J, Yun SC, Lee CW, Hong MK,­Lee JH, ParkSW. Impact of intravascular ultrasound guidance on long-termmortality­in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc­Interv 2009;2(3):167–177

706. Witzenbichler B, Maehara A, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC,­Henry TD, Cox DA, Duffy PL, Brodie BR, Stuckey TD, Mazzaferri EL Jr., Xu K,­Parise H, Mehran R, Mintz GS, Stone GW. Relationship Between Intravascular­Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment­of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES)­Study. Circulation 2014;129(4):463–470

707. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B,­Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C,­Dudek D, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Gonzalo N,­Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J,­Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP,­Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S,­Okura H, Otake H, Pietrasik A, Prati F, Raber L, Radu MD, Rieber J, Riga M,­Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J,­Siegel E, Sonoda S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T,­Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van­Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G, International Working­Groupfor Intravascular Optical CoherenceT. Consensus standards for acquisition,­measurement, and reporting of intravascular optical coherence tomography­studies: a report from the InternationalWorking Group for Intravascular Optical­Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;­59(12):1058–1072

708. Cassar A, MatsuoY, Herrmann J, Li J, Lennon RJ, Gulati R, Lerman LO, Kushwaha SS,­Lerman A. Coronary atherosclerosis with vulnerable plaque and complicated­lesions in transplant recipients: new insight into cardiac allograft vasculopathy by­optical coherence tomography. Eur Heart J 2013;34(33):2610–2617

709. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T, Barlis P, Tearney GJ,­Jang IK, Arbustini E, Bezerra HG, Ozaki Y, Bruining N, Dudek D, Radu M, Erglis A,­Motreff P, Alfonso F, Toutouzas K, Gonzalo N, Tamburino C, Adriaenssens T,­Pinto F, Serruys PW, Di Mario C. Expert review document part 2: methodology,­terminology and clinical applications of optical coherence tomography for the assessment­of interventional procedures. Eur Heart J 2012;33(20):2513–2520

710. Radu MD, Raber L, Heo J, Gogas BD, Jorgensen E, Kelbaek H, Muramatsu T,­Farooq V, Helqvist S, Garcia-Garcia HM, Windecker S, Saunamaki K,­Serruys PW. Natural history of optical coherence tomography-detected­non-flow-limiting edge dissections following drug-eluting stent implantation. Euro-­Intervention 2014;9(9):1085–1094

711. Prati F, Di Vito L, Biondi-Zoccai G, Occhipinti M, La Manna A, Tamburino C,­Burzotta F, Trani C, Porto I, Ramazzotti V, Imola F, Manzoli A, Materia L,­Cremonesi A, Albertucci M. Angiography alone vs. angiography plus optical coherence­tomography to guide decision-making during percutaneous coronary intervention:­the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous­Coronary Intervention (CLI-OPCI) study. EuroIntervention 2012;8(7):823–829

712. Kang SJ, Mintz GS, Akasaka T, ParkDW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan­Lee C, Park SW, Park SJ. Optical coherence tomographic analysis of in-stent­neoatherosclerosis after drug-eluting stent implantation. Circulation 2011;­123(25):2954–2963

713. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ,­Koolen JJ. Measurement of fractional flow reserve to assess the functional severity­of coronary-artery stenoses. N Engl J Med 1996;334(26):1703–1708

714. Sen S, Escaned J, Malik IS, MikhailGW, Foale RA, Mila R, Tarkin J, Petraco R, Broyd C,­Jabbour R, Sethi A, Baker CS, Bellamy M, Al-Bustami M, Hackett D, Khan M,­Lefroy D, Parker KH, Hughes AD, Francis DP, Di Mario C, Mayet J, Davies JE. Development­and validation of a new adenosine-independent index of stenosis severity­from coronary wave-intensity analysis: results of the ADVISE (ADenosine­Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol 2012;­59(15):1392–1402

715. Nakazato R, Park HB, Berman DS, Gransar H, Koo BK, Erglis A, Lin FY,DunningAM,­Budoff MJ, Malpeso J, Leipsic J, Min JK. Non-invasive Fractional Flow Reserve­Derived from CT Angiography (FFRCT) for Coronary Lesions of Intermediate­Stenosis Severity: Results from the DeFACTO study. Circ Cardiovasc Imaging­2013;6(6):881–889

716. Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, Dunning A, DeFrance T,­Lansky A, Leipsic J, Min JK. Diagnosis of ischemia-causing coronary stenoses by noninvasive­fractional flow reserve computed from coronary computed tomographic­angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis­of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow­Reserve) study. J Am Coll Cardiol 2011;58(19):1989–1997

717. Patel Y, Depta JP, Novak E, Yeung M, Lavine K, Banerjee S, Lin CH, Zajarias A,­Kurz HI, Lasala JM, Bach RG, Singh J. Long-term outcomes with use of intravascular­ultrasound for the treatment of coronary bifurcation lesions. Am J Cardiol 2012;­109(7):960–965

718. Myler RK, Shaw RE, Stertzer SH, Hecht HS, Ryan C, Rosenblum J, Cumberland DC,­Murphy MC, Hansell HN, Hidalgo B. Lesion morphology and coronary angioplasty:­current experience and analysis. J Am Coll Cardiol 1992;19(7):1641–1652

719. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P,­Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS,­Galloe A, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S,­Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L Randomized study on simple vs. complex stenting of coronary artery bifurcation­lesions: the Nordic bifurcation study. Circulation 2006;114(18):1955–1961

720. Latib A, Colombo A. Bifurcation disease: what do we know, what should we do?­JACC Cardiovasc Interv 2008;1(3):218–226

721. Al Suwaidi J, YehW, Cohen HA, DetreKM, WilliamsDO,HolmesDRJr. Immediate­and one-year outcome in patients with coronary bifurcation lesions in the modern­era (NHLBI dynamic registry). Am J Cardiol 2001;87(10):1139–1144

722. Stinis CT, Hu SP, Price MJ, Teirstein PS. Three-year outcome of drug-eluting stent­implantation for coronary artery bifurcation lesions. Catheter Cardiovasc Interv 2010;­75(3):309–314

723. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F,­Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C,­Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis­after successful implantation of drug-eluting stents. JAMA 2005;293(17):­2126–2130

724. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr., Spanos V, Louvard Y,­Desmedt B, Di Mario C, Leon MB. Randomized study to evaluate sirolimus-eluting­stents implanted at coronary bifurcation lesions. Circulation 2004;109(10):­1244–1249

725. Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations J Am Coll Cardiol 2005;46(8):1446–1455

726. Maeng M, Holm NR, Erglis A, Kumsars I, Niemela M, Kervinen K, Jensen JS, Galloe A,­Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O,­Rotevatn S, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S,­Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Christiansen EH,­Lassen JF, Thuesen L. Long-term results after simple vs. complex stenting of coronary­artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results. J­Am Coll Cardiol 2013;62(1):30–34

727. Ferenc M, Gick M, Kienzle RP, Bestehorn HP,Werner KD, Comberg T, Zhao M,­Buettner HJ, Neumann FJ. Long-term outcome of percutaneous catheter­intervention for de novo coronary bifurcation lesions with drug-eluting stents or­bare-metal stents. Am Heart J 2010;159(3):454–461

728. Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG,­Bennett L, Holmberg S, Cotton JM, Glennon PE, Thomas MR, Maccarthy PA,­Baumbach A, Mulvihill NT, Henderson RA, Redwood SR, Starkey IR, Stables RH Randomized trial of simple vs. complex drug-eluting stenting for bifurcation­lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies Circulation 2010;121(10):1235–1243

729. BehanMW, Holm NR, Curzen NP, Erglis A, Stables RH, de Belder AJ, Niemela M,­Cooter N, Chew DP, Steigen TK, Oldroyd KG, Jensen JS, Lassen JF, Thuesen L,­Hildick-Smith D. Simple or complex stenting for bifurcation coronary lesions: a­patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation­Coronary Study. Circ Cardiovasc Interv 2011;4(1):57–64

730. Chen SL, SantosoT, Zhang JJ,YeF,XuYW, FuQ, Kan J, Paiboon C,ZhouY, Ding SQ,­Kwan TW. A randomized clinical study comparing double kissing crush with provisional­stenting for treatment of coronary bifurcation lesions: results from the­DKCRUSH-II (Double Kissing Crush vs. Provisional Stenting Technique for Treatment­of Coronary Bifurcation Lesions) trial. J Am Coll Cardiol 2011;57(8):914–920

731. Assali AR, Vaknin-Assa H, Lev E, Teplitsky I, Dvir D, Brosh D, Bental T, Battler A,­Kornowski R. Drug eluting stenting in bifurcation coronary lesions long-term­results applying a systematic treatment strategy. Catheter Cardiovasc Interv 2012;­79(4):615–622

732. Song YB, Hahn JY, Song PS, Yang JH, Choi JH, Choi SH, Lee SH, Gwon HC. Randomized­comparison of conservative vs. aggressive strategy for provisional side­branch intervention in coronary bifurcation lesions: results from the SMARTSTRATEGY­(Smart Angioplasty Research Team-Optimal Strategy for Side­Branch Intervention in Coronary Bifurcation Lesions) randomized trial. JACC Cardiovasc­Interv 2012;5(11):1133–1140

733. Niemela M, Kervinen K, Erglis A, Holm NR, Maeng M, Christiansen EH, Kumsars I,­Jegere S, Dombrovskis A, Gunnes P, Stavnes S, Steigen TK, Trovik T, Eskola M,­Vikman S, Romppanen H, Makikallio T, Hansen KN, Thayssen P, Aberge L,­Jensen LO, Hervold A, Airaksinen J, Pietila M, Frobert O, Kellerth T, Ravkilde J,­Aaroe J, Jensen JS, Helqvist S, Sjogren I, James S, Miettinen H, Lassen JF,­Thuesen L. Randomized comparison of final kissing balloon dilatation vs. no final­kissing balloon dilatation in patients with coronary bifurcation lesions treated­with main vessel stenting: the Nordic-Baltic Bifurcation Study III. Circulation 2011;­123(1):79–86

734. GwonHC,Hahn JY,KooBK, Song YB,Choi SH, Choi JH, Lee SH, JeongMH,Kim HS,­SeongIW, Yang JY, RhaSW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ. Final kissing­ballooning and long-termclinical outcomes in coronary bifurcation lesions treated­with 1-stent technique: results from the COBIS registry. Heart 2012;98(3):­225–231

735. Mylotte D, Meftout B, Moynagh A, Vaquerizo B, Darremont O, Silvestri M,­Louvard Y, Leymarie JL, Morice MC, Lefevre T, Garot P. Unprotected left main­stenting in the real world: five-year outcomes of the French Left Main Taxus registry EuroIntervention 2012;8(8):970–981

736. Teirstein PS, Price MJ. Left main percutaneous coronary intervention. J Am Coll­Cardiol 2012;60(17):1605–1613

737. Chen SL, Zhang Y, Xu B, Ye F, Zhang J, Tian N, Liu Z, Qian X, Ding S, Li F, Zhang A,­Liu Y, Lin S. Five-year clinical follow-up of unprotected left main bifurcation lesion­stenting: one-stent vs. two-stent techniques vs. double-kissing crush technique EuroIntervention 2012;8(7):803–14

738. Di Mario C, Werner GS, Sianos G, Galassi AR, Buttner J, Dudek D, Chevalier B,­Lefevre T, Schofer J, Koolen J, Sievert H, Reimers B, Fajadet J, Colombo A,­Gershlick A, Serruys PW, Reifart N. European perspective in the recanalisation­of Chronic Total Occlusions (CTO): consensus document from the EuroCTO­Club. EuroIntervention 2007;3(1):30–43

739. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol­2005;95(9):1088–1091

740. Claessen BE, Dangas GD, Godino C, Lee SW, Obunai K, Carlino M, Suh JW,­Leon MB, Di Mario C, Park SJ, StoneGW, Moses JW, Colombo A, Mehran R. Longterm­clinical outcomes of percutaneous coronary intervention for chronic total­occlusions in patients with vs. without diabetes mellitus. Am J Cardiol 2011;­108(7):924–931

741. Mehran R, Claessen BE, Godino C, Dangas GD, Obunai K, Kanwal S, Carlino M,­Henriques JP, Di Mario C, Kim YH, Park SJ, Stone GW, Leon MB, Moses JW,­Colombo A. Long-term outcome of percutaneous coronary intervention for­chronic total occlusions. JACC Cardiovasc Interv 2011;4(9):952–961

742. Jones DA, Weerackody R, Rathod K, Behar J, Gallagher S, Knight CJ, Kapur A,­Jain AK, Rothman MT, Thompson CA, Mathur A, Wragg A, Smith EJ. Successful­recanalization of chronic total occlusions is associated with improved long-term­survival. JACC Cardiovasc Interv 2012;5(4):380–388

743. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions:­a systematic review and meta-analysis. Am Heart J 2010;160(1):179–187

744. Hannan EL, Racz M, Holmes DR, King SB 3rd,Walford G, Ambrose JA, Sharma S,­Katz S, Clark LT, Jones RH. Impact of completeness of percutaneous coronary­intervention revascularization on long-term outcomes in the stent era. Circulation­2006;113(20):2406–2412

745. Grantham JA, Jones PG, Cannon L, Spertus JA. Quantifying the early health status­benefits of successful chronic total occlusion recanalization: Results from the Flow-­Cardia’s Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial Circ Cardiovasc Qual Outcomes 2010;3(3):284–290

746. Werner GS, Hochadel M, Zeymer U, Kerber S, Schumacher B, Grube E,­Hauptmann KE, Brueck M, Zahn R, Senges J. Contemporary success and complication­rates of percutaneous coronary intervention for chronic total coronary occlusions:­results from the ALKK quality control registry of 2006. EuroIntervention 2010;­6(3):361–366

747. Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S,­Gannot S, Samuel M, Weisbrod M, Bierstone D, Sparkes JD, Wright GA,­Strauss BH. Current perspectives on coronary chronic total occlusions: the Canadian­Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012;­59(11):991–997

748. Morino Y, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K,­Shibata Y, Hiasa Y, Doi O, Yamashita T, Morimoto T, Abe M, Hinohara T,­Mitsudo K. In-hospital outcomes of contemporary percutaneous coronary intervention­in patients with chronic total occlusion insights from the J-CTO Registry­(Multicenter CTO Registry in Japan). JACC Cardiovasc Interv 2010;3(2):143–151

749. Surmely JF, Tsuchikane E, Katoh O, Nishida Y, Nakayama M, Nakamura S, Oida A,­Hattori E, Suzuki T. New concept for CTO recanalization using controlled antegrade­and retrograde subintimal tracking: the CART technique. J Invasive Cardiol­2006;18(7):334–338

750. Sianos G, Barlis P, Di Mario C, Papafaklis MI, Buttner J, Galassi AR, Schofer J,­Werner G, Lefevre T, Louvard Y, Serruys PW, Reifart N. European experience­with the retrograde approach for the recanalisation of coronary artery chronic­total occlusions. A report on behalf of the euroCTO club. EuroIntervention 2008;­4(1):84–92

751. Colmenarez HJ, Escaned J, Fernandez C, Lobo L, Cano S, del Angel JG, Alfonso F,­Jimenez P, Banuelos C, Gonzalo N, Garcia E, Hernandez R, Macaya C. Efficacy­and safety of drug-eluting stents in chronic total coronary occlusion recanalization:­a systematic review and meta-analysis. J Am Coll Cardiol 2010;55(17):1854–1866

752. Saeed B, Kandzari DE, Agostoni P, LombardiWL,Rangan BV, Banerjee S, Brilakis ES Use of drug-eluting stents for chronic total occlusions: a systematic review and­meta-analysis. Catheter Cardiovasc Interv 2011;77(3):315–332

753. Van den Branden BJ, Rahel BM, Laarman GJ, Slagboom T, Kelder JC, Ten Berg JM,­Suttorp MJ. Five-year clinical outcome after primary stenting of totally occluded­native coronary arteries: a randomised comparison of bare metal stent implantation­with sirolimus-eluting stent implantation for the treatment of total coronary­occlusions (PRISON II study). EuroIntervention 2012;7(10):1189–1196

754. Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, Curtus JP, Brennan JM,­Sedrakyan A, Messenger JC, Douglas PS. Comparative effectiveness of drug-eluting­vs. bare-metal stents in elderly patients undergoing revascularization of chronic­total coronary occlusions: results from the National Cardiovascular Data Registry,­2005–2008. JACC Cardiovasc Interv 2012;5(10):1054–1061

755. Jokhi P, Curzen N. Percutaneous coronary intervention of ostial lesions. EuroIntervention­2009;5(4):511–514

756. Pritchard CL, Mudd JG, Barner HB. Coronary ostial stenosis. Circulation 1975;52(1):­46–48

757. Thompson R. Isolated coronary ostial stenosis in women. J Am Coll Cardiol 1986;­7(5):997–1003

758. Miller GA, Honey M, el-Sayed H. Isolated coronary ostial stenosis. Cathet Cardiovasc­Diagn 1986;12(1):30–34

759. Rissanen V. Occurrence of coronary ostial stenosis in a necropsy series of myocardial­infarction, sudden death, and violent death. Br Heart J 1975;37(2):182–191

760. Popma JJ, Dick RJ, Haudenschild CC, Topol EJ, Ellis SG. Atherectomy of right coronary­ostial stenoses: initial and long-term results, technical features and histologic­findings. Am J Cardiol 1991;67(5):431–433

761. Koh JS, Koo BK, Kim JH, Yang HM, ParkKW, Kang HJ, Kim HS, Oh BH, Park YB. Relationship­between fractionalflowreserve and angiographic and intravascular ultrasound­parameters in ostial lesions: major epicardial vessel vs. side branch ostial­lesions. JACC Cardiovasc Interv 2012;5(4):409–415

762. Muramatsu T, Tsukahara R, Ho M, Ito S, Inoue T, Akimoto T, Hirano K. Efficacy of­cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive­Cardiol 1999;11(4):201–206

763. Kurbaan AS, Kelly PA, Sigwart U. Cutting balloon angioplasty and stenting for­aorto-ostial lesions. Heart 1997;77(4):350–352

764. Chung CM, Nakamura S, Tanaka K, Tanigawa J, Kitano K, Akiyama T, Matoba Y,­Katoh O. Comparison of cutting balloon vs. stenting alone in small branch ostial­lesions of native coronary arteries. Circ J 2003;67(1):21–25

765. Popma JJ, BroganWC3rd, Pichard AD, Satler LF, Kent KM, Mintz GS, Leon MB. Rotational­coronary atherectomy of ostial stenoses. Am J Cardiol 1993;71(5):­436–438

766. Schwartz L, Morsi A. The draw-back stent deployment technique: a strategy for the­treatment of coronary branch ostial lesions. J Invasive Cardiol 2002;14(2):66–71

767. Szabo S, Abramowitz B, Vaitkus P. New technique of aorto-ostial stent placement Am J Cardiol 2005;96:p212H

768. Gutierrez-Chico JL, Villanueva-Benito I, Villanueva-Montoto L, Vazquez-­Fernandez S, Kleinecke C, Gielen S, Iniguez-Romo A. Szabo technique vs. conventional­angiographic placement in bifurcations 010–001 of Medina and in­aorto-ostial stenting: angiographic and procedural results. EuroIntervention 2010;­5(7):801–808

769. Park DW, Hong MK, Suh IW, Hwang ES, Lee SW, Jeong YH, Kim YH, Lee CW,­Kim JJ, ParkSW, Park SJ. Results and predictors of angiographic restenosis and longterm­adverse cardiac events after drug-eluting stent implantation for aorto-ostial­coronary artery disease. Am J Cardiol 2007;99(6):760–765

770. Al-Lamee R, Ielasi A, Latib A, Godino C, Mussardo M, Arioli F, Figin F, Piraino D,­Carlino M, Montorfano M, Chieffo A, Colombo A. Comparison of long-term clinical­and angiographic outcomes following implantation of bare metal stents and­drug-eluting stents in aorto-ostial lesions. Am J Cardiol 2011;108(8):1055–1060

771. Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airoldi F, Chieffo A,­Stankovic G, Vitrella G, Carlino M, Corvaja N, Briguori C, Colombo A. Clinical­and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial­lesions. J Am Coll Cardiol 2004;44(5):967–971

772. Lee SW, Kim SH, Kim SO, Han S, Kim YH, Park DW, Kang SJ, Lee CW, Park SW,­Park SJ. Comparative long-term efficacy and safety of drug-eluting stent vs. coronary­artery bypass grafting in ostial left main coronary artery disease: analysis of the­MAIN-COMPARE registry. Catheter Cardiovasc Interv 2012;80(2):206–212

773. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E,­Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines­for percutaneous coronary interventions. The task force for percutaneous coronary­interventions of the European Society of Cardiology. Eur Heart J 2005;26:­804–847

774. Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R,­Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH,­Siegbahn A, Steg PG, StoreyRF, Van deWerf F, FV. Antiplatelet agents for the treatment­and prevention of atherothrombosis. Eur Heart J 2011;32(23):2922–2932

775. Patrono C, Rodriguez LA, Landolfi R, Baigent C. Low-Dose Aspirin for the Prevention­of Atherothrombosis. N Eng J Med. 2005;353:2373–2383

776. Antiplatelet tc. Collaborative meta-analysis of randomised trials of antiplatelet­therapy for prevention of death, myocardial infarction, and stroke in high risk­patients. BMJ 2002;324:71–86

777. Bellemain-Appaix A, O’Connor SA, Silvain J, Cucherat M, Beygui F, Barthe´le´my O,­Collet JP, Jacq L, Bernasconi F, Montalescot G. Association of Clopidogrel Pretreatment­With Mortality, Cardiovascular Events, and Major Bleeding Among Patients­Undergoing Percutaneous Coronary Intervention: A Systematic Review and­Meta-analysis. JAMA 2012;308(23):2507–2516

778. Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S,­Robbins M, Garratt KN, Bertrand OF, Stillablower ME, Aragon JR, Kandzari DE,­StinisCT, Lee MS, Manoukian SV, CannonCP, Schork NJ, Topol EJ, for GI. Standardvs high-dose clopidogrel based on platelet function testing after percutaneous coronary­intervention: the GRAVITAS randomized trial. JAMA 2011;305(11):­1097–1105

779. Grines CL, Bonow RO, Casey DE Jr., Gardner TJ, Lockhart PB, Moliterno DJ,­O’Gara P, Whitlow P, American Heart A, American College of C, Society for Cardiovascular­A, Interventions, American College of S, American Dental A, American­College of P. Prevention of premature discontinuation of dual antiplatelet therapy­in patients with coronary artery stents: a science advisory from the American Heart­Association, American College of Cardiology, Society for Cardiovascular Angiography­and Interventions, American College of Surgeons, and American Dental Association,­with representation from the American College of Physicians. Circulation­2007;115:813–818

780. Valgimigli M, Percoco G, Barbieri D, Ferrari F, Guardigli G, Parrinello G,­Soukhomovskaia O, Ferrari R. The additive value of tirofiban administered with­the high-dose bolus in the prevention of ischemic complications during high-risk­coronary angioplasty: the ADVANCE Trial. J Am Coll Cardiol 2004;44(1):14–19

781. Biondi-Zoccai G, Valgimigli M, Margheri M, Marzocchi A, Lettieri C, Stabile A,­Petronio AS, Binetti G, Bolognese L, Bellone P, Sardella G, Contarini M,­Sheiban I, Marra S, Piscione F, Romeo F, Colombo A, Sangiorgi G. Assessing the­role of eptifibatide in patients with diffuse coronary disease undergoing­drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis­Trial. Am Heart J 2012;163(5):835.e1–e7

Не нашли, что искали? Воспользуйтесь поиском: